Abcam plc (ABCM)

Etorro trading 970x250
Abcam plc (ABCM) Logo

About Abcam plc

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom. Address: Discovery Drive, Cambridge, United Kingdom, CB2 0AX

Abcam plc News and around…

Latest news about Abcam plc (ABCM) common stock and company :

ABCAM PLC First Half Trading Update
20 Jul, 2022 Yahoo! Finance

Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period ending 30 June 2022. The Company will release its full results for the six-month period on 12 September 2022.

Earnings Scheduled For July 20, 2022
20 Jul, 2022 FinancialContent

Companies Reporting Before The Bell • Wipro (NYSE:WIT) is projected to report quarterly earnings at $0.08 per share on ...

Great news for Abcam plc (LON:ABC): Insiders acquired stock in large numbers last year
13 Jul, 2022 Yahoo! Finance

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Abcam: Appointment of Vice President of Investor Relations
27 Jun, 2022 Yahoo! Finance

Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations.

Abcam plc's (LON:ABC) Intrinsic Value Is Potentially 43% Above Its Share Price
18 Jun, 2022 Yahoo! Finance

Today we will run through one way of estimating the intrinsic value of Abcam plc ( LON:ABC ) by taking the expected...

Are Abcam plc's (LON:ABC) Mixed Financials Driving The Negative Sentiment?
02 May, 2022 Yahoo! Finance

Abcam (LON:ABC) has had a rough month with its share price down 11%. It is possible that the markets have ignored the...

Abcam the most awarded company at 2022 industry awards
25 Mar, 2022 Yahoo! Finance

Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance discoveries and deliver faster breakthroughs.

Wall Street Analysts Predict a 27% Upside in Abcam PLC Sponsored ADR (ABCM): Here's What You Should Know
18 Mar, 2022 Yahoo! Finance

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Abcam PLC Sponsored ADR (ABCM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021
14 Mar, 2022 Yahoo! Finance

Growing demand for Abcam’s portfolio of in-house products drives calendar 2021 revenues up by 22% at constant exchange rates Acquisition of BioVision completed 26 October 2021 CAMBRIDGE, United Kingdom, March 14, 2022 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its final results for the 18-month period ended 31 December 2021 (the ‘period’). The Group’s accounting refe

Investing in Abcam (LON:ABC) five years ago would have delivered you a 38% gain
10 Mar, 2022 Yahoo! Finance

While Abcam plc ( LON:ABC ) shareholders are probably generally happy, the stock hasn't had particularly good run...

Abcam Becomes Oversold (ABCM)
22 Feb, 2022 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications
01 Feb, 2022 FinancialContent

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announced a licensing agreement under which Abcam will use a proprietary Twist VHH phage library for antibody discovery, development and commercialization for diagnostic and research applications.

Is Abcam plc (LON:ABC) Trading At A 20% Discount?
09 Jan, 2022 Yahoo! Finance

Today we will run through one way of estimating the intrinsic value of Abcam plc ( LON:ABC ) by projecting its future...

45 Biggest Movers From Yesterday
05 Jan, 2022 FinancialContent

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged ...

34 Stocks Moving In Tuesday's Mid-Day Session
04 Jan, 2022 FinancialContent

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
04 Jan, 2022 FinancialContent

Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The ...

23 Stocks Moving in Tuesday's Pre-Market Session
04 Jan, 2022 FinancialContent

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and ...

Alamar Biosciences partners with Abcam to drive understanding of the human proteome
04 Jan, 2022 Yahoo! Finance

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership to further understanding of the human proteome.

Abcam Reaches Analyst Target Price
28 Dec, 2021 FinancialContent

In recent trading, shares of Abcam PLC (ABCM) have crossed above the average analyst 12-month target price of $22.33, changing hands for $23.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..

Can Mixed Fundamentals Have A Negative Impact on Abcam plc (LON:ABC) Current Share Price Momentum?
10 Nov, 2021 Yahoo! Finance

Abcam (LON:ABC) has had a great run on the share market with its stock up by a significant 15% over the last three...

Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
02 Nov, 2021 Yahoo! Finance

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a strategic development and supply partnership.

Abcam completes $340m strategic acquisition and expands kit capacity and capability
27 Oct, 2021 Yahoo! Finance

Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, OR.

29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
13 Sep, 2021 Yahoo! Finance

CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its interim results for the six- and 12-month periods ended 30 June 2021 (the ‘period’). The Group’s accounting reference date has changed from 30 June to 31 December1, therefore these interim financial statements report on both a six- and 12-month period. SUMMARY PERFORMANCE 12 mont

Earnings Scheduled For September 13, 2021
13 Sep, 2021 FinancialContent

Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third ...

Abcam To Acquire Supplier BioVision For $340M In Cash
02 Aug, 2021 FinancialContent

Abcam plc(NASDAQ: ABCM)has agreed to acquireBioVision Inc, a wholly-ownedBoai NKY Medical Holdings ...

Stocks That Hit 52-Week Lows On Tuesday
20 Jul, 2021 FinancialContent

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the ...

Abcam Enters Oversold Territory (ABCM)
19 Jul, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

2 of the Safest Biotech Stocks You'll Find Today
29 May, 2021 FinancialContent

They provide the infrastructure and sell the tools that biomedical researchers need to make breakthroughs.

Avacta Announces Distribution Agreement With ABCAM plc
06 Apr, 2021 FinancialContent

Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a global distribution agreement with ABCAM plc (AIM: ABC; NASDAQ: ABCM) to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.

Abcam is Now Oversold (ABCM)
08 Mar, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Abcam plc (ABCM) is a NASDAQ Common Stock listed in , ,

970x250